1. Antibodies
  2. Primary Antibodies
  3. Monoclonal Antibodies Flow Cytometry Antibodies
  4. NAPEPLD (NAPE-PLD) Antibody (YA7783)

NAPEPLD (NAPE-PLD) Antibody (YA7783)

Cat. No.: HY-P88099
User Guide for Antibodies Technical Support

NAPEPLD (NAPE-PLD) Antibody (YA7783) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to NAPEPLD (NAPE-PLD).

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

사이즈 가격 재고
20 μL Ask For Quote & Lead Time
50 μL Ask For Quote & Lead Time
100 μL Ask For Quote & Lead Time

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

Top Publications Citing Use of Products
  • WB: Western Blot;
  • IHC-P: Immunohistochemistry-Paraffin;
  • IHC-F: Immunohistochemistry-Frozen;
  • ICC/IF: Immunocytochemistry/Immunofluorescence;
  • IF-Tissue: Immunofluorescence-Tissue;
  • mIHC: Multiplex Immunohistochemical;
  • IP: Immunoprecipitation;
  • ChIP: Chromatin Immunoprecipitation;
  • FC: Flow Cytometry;
  • ELISA: Enzyme Linked Immunosorbent Assay
  • Product Detail

  • Background

  • 제품 설명

제품 설명

NAPEPLD (NAPE-PLD) Antibody (YA7783) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to NAPEPLD (NAPE-PLD).

Host

Mouse

Clonality

Monoclonal

분자량

Predicted band size: 45.4 kDa

Species Reactivity
Human, Mouse, Rat
SwissProt ID
Immunogen

Full length human recombinant protein of human NAPEPLD produced in HEK293T cell.

Application &
Dilution Ratio
Application Dilution Ratio
IHC-P
IHC-P: Immunohistochemistry-Paraffin
1:150-500
ICC/IF
ICC/IF: Immunocytochemistry/Immunofluorescence
1:100-250
FC
FC: Flow Cytometry
1:100
Sensitivity Endogenous Purity Affinity purified
Conjugation Non-conjugated Modification Unmodified
Isotype IgG2a  
Appearance

Liquid

Formulation

Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

선적

Shipping with blue ice.

Background
Function:D-type phospholipase that hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce bioactive N-acylethanolamines/fatty acid ethanolamides (NAEs/FAEs) and phosphatidic acid (PubMed:14634025, PubMed:16527816, PubMed:25684574, PubMed:27571266). Cleaves the terminal phosphodiester bond of diacyl- and alkenylacyl-NAPEs, primarily playing a role in the generation of long-chain saturated and monounsaturated NAEs in the brain (By similarity). May control NAPE homeostasis in dopaminergic neuron membranes and regulate neuron survival, partly through RAC1 activation (By similarity). As a regulator of lipid metabolism in the adipose tissue, mediates the crosstalk between adipocytes, gut microbiota and immune cells to control body temperature and weight. In particular, regulates energy homeostasis by promoting cold-induced brown or beige adipocyte differentiation program to generate heat from fatty acids and glucose. Has limited D-type phospholipase activity toward N-acyl lyso-NAPEs (By similarity)
Subcellular Localization:Golgi apparatus membrane,Early endosome membrane,Nucleus envelope,Nucleus, nucleoplasm
Expression:
Tissue_Specificity: Widely expressed. Highest expression in brain, kidney and testis (at protein level). Expressed in adipose tissue (at protein level)
Isoforms & Post-Translational Modification:Q6IQ20: 393 amino acids, molecular weight 45596 Da.
Subunit:Homodimer
Synonyms
FMP30; NAPE-PLD
각종 서류

NAPEPLD (NAPE-PLD) Antibody (YA7783) Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

최근 본 상품:

온라인 문의

Your information is safe with us. * Required Fields.

상품명

 

Requested Quantity *

고객명 *

 

호칭

메일주소 *

 

전화번호 *

Department

 

회사명 *

City

Country or Region *

     

비고

대량구매 문의

Inquiry Information

상품명:
NAPEPLD (NAPE-PLD) Antibody (YA7783)
Cat. No.:
HY-P88099
수량:
MCE Japan Authorized Agent: